Literature DB >> 15174051

An investigation into the human serum "interactome".

Ming Zhou1, David A Lucas, King C Chan, Haleem J Issaq, Emanuel F Petricoin, Lance A Liotta, Timothy D Veenstra, Thomas P Conrads.   

Abstract

The protein content of human serum is composed of a millieu of proteins from almost every type of cell and tissue within the body. The serum proteome has been shown to contain information that directly reflects pathophysiological states and represents an invaluable source of diagnostic information for a variety of different diseases. Unfortunately, the dynamic range of protein abundance, ranging from >> mg/mL level to << pg/mL level, renders complete characterization of this proteome nearly impossible with current analytical methods. To study low-abundance proteins, which have potential value for clinical diagnosis, the high-abundant species, such as immunoglobulins and albumin, are generally eliminated as the first step in many analytical protocols. This step, however, is hypothesized to concomitantly remove proteins/peptides associated with the high-abundant proteins targeted for depletion. In this study, immunoprecipitation was combined with microcapillary reversed-phase liquid chromatography (microRPLC) coupled on-line with tandem mass spectrometry (MS/MS) to investigate the low-molecular-weight proteins/peptides that associate with the most abundant species in serum. By this targeted isolation of select highly abundant serum proteins, the associated proteins/peptides can be enriched and effectively identified by microRPLC-MS/MS. Among the 210 proteins identified, 73% and 67% were not found in previous studies of the low-molecular-weight or whole-serum proteome, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174051     DOI: 10.1002/elps.200405866

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  74 in total

Review 1.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

2.  Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.

Authors:  Claudia Fredolini; Francesco Meani; Alessandra Luchini; Weidong Zhou; Paul Russo; Mark Ross; Alexis Patanarut; Davide Tamburro; Guido Gambara; David Ornstein; Franco Odicino; Monica Ragnoli; Antonella Ravaggi; Francesco Novelli; Devis Collura; Leonardo D'Urso; Giovanni Muto; Claudio Belluco; Sergio Pecorelli; Lance Liotta; Emanuel F Petricoin
Journal:  AAPS J       Date:  2010-06-12       Impact factor: 4.009

3.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

4.  Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.

Authors:  Lance A Liotta; Emanuel F Petricoin
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

5.  Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Heather M Mottaz; Marina A Gritsenko; Angela D Norbeck; Ronald J Moore; Samuel O Purvine; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-07-19       Impact factor: 5.911

Review 6.  The blood peptidome: a higher dimension of information content for cancer biomarker discovery.

Authors:  Emanuel F Petricoin; Claudio Belluco; Robyn P Araujo; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2006-11-09       Impact factor: 60.716

Review 7.  Calorimetric analysis of the plasma proteome.

Authors:  Nichola C Garbett; James J Miller; A Bennett Jenson; Jonathan B Chaires
Journal:  Semin Nephrol       Date:  2007-11       Impact factor: 5.299

8.  Comparison of nanotube-protein corona composition in cell culture media.

Authors:  Jonathan H Shannahan; Jared M Brown; Ran Chen; Pu Chun Ke; Xianyin Lai; Somenath Mitra; Frank A Witzmann
Journal:  Small       Date:  2013-01-16       Impact factor: 13.281

9.  Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples.

Authors:  Rebekah L Gundry; Melanie Y White; Julie Nogee; Irina Tchernyshyov; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

10.  Lipoic acid glyco-conjugates, a new class of agents for controlling nonspecific adsorption of blood serum at biointerfaces for biosensor and biomedical applications.

Authors:  Yanyan Wang; Kheireddine El-Boubbou; Hovig Kouyoumdjian; Bin Sun; Xuefei Huang; Xiangqun Zeng
Journal:  Langmuir       Date:  2010-03-16       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.